URSULA WILLIAMS: Open Payments
NPI 1992038053 · BARNEVELD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$598 in 31 payments from 11 companies in 2025. Trend: 2023 $244 · 2024 $475 · 2025 $598
Food & beverage: $598
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $129 |
| PFIZER INC. | 5 | $86 |
| AstraZeneca Pharmaceuticals LP | 4 | $83 |
| Lilly USA, LLC | 4 | $80 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| Otsuka America Pharmaceutical, Inc. | 2 | $46 |
| Axsome Therapeutics, Inc. | 2 | $41 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $15 |
| Exact Sciences Corporation | 1 | $15 |
Products named: JARDIANCE, Wegovy, REXULTI, BREZTRI, Ozempic, Auvelity, ELIQUIS, SHINGRIX.
Industry payments across NY — which companies pay providers there.
